Mapping amyloid beta predictors of entorhinal tau in preclinical Alzheimer's disease
Alzheimer's & Dementia · 2025-02 · 21 (2)
DOI: 10.1002/alz.14499 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 08.01.2025. Verfasst von Jafar Zamani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Computational Brain Research and Intervention (C-Brain) Lab, Department of Psychiatry and Behavioral Sciences, School of Medicine, Stanford Universit…. Hauptthemen laut MEDLINE: Alzheimer Disease, tau Proteins, Amyloid beta-Peptides, Entorhinal Cortex. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIMH NIH HHS, National Institute on Aging.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Amyloid beta (Aβ) plaques and hyperphosphorylated tau in the entorhinal regions are key Alzheimer's disease (AD) markers, but the spatial Aβ pathways influencing tau pathology remain unclear. METHODS We applied predictive modeling to identify Aβ standardized uptake value ratio (SUVR) spatial patterns that predict entorhinal tau levels, future hippocampal volume, and Preclinical Alzheimer's Cognitive Composite (PACC) scores at 5‐year follow‐up. The model was trained on Alzheimer's Disease Neuroimaging Initiative (ADNI) ( N = 237), incorporating amyloid‐PET (positron emission tomography), tau‐PET, magnetic resonance imaging (MRI), and cognitive data, and validated on Harvard Aging Brain Study (HABS) ( N = 276). RESULTS The model accurately predicted entorhinal tau levels ( r = 0.48, p < 0.0001), future hippocampal volume ( r = 0.24, p = 0.002), and PACC scores ( r = 0.35, p < 0.0001) based on regional Aβ. DISCUSSION Aβ in the rostral middle frontal, medial orbitofrontal, and striatal regions predict entorhinal tau levels, future hippocampal volume, and PACC scores, indicating their potential as early biomarkers in AD prediction models. Highlights Positron emission tomography (PET) imaging reveals amyloid beta (Aβ) patterns predicting entorhinal tau levels in preclinical Alzheimer's disease (AD). Aβ in medial orbitofrontal, rostral middle frontal, and nucleus accumbens best predicts tau. Aβ distribution in these regions predicts future hippocampal neurodegeneration and cognitive decline. Model validated with Alzheimer's Disease Neuroimaging Initiative (ADNI) and Harvard Aging Brain Study (HABS) data sets, showing robustness and reproducibility. Findings suggest early Aβ patterns can aid in diagnosing AD and guide anti‐Aβ therapies
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Computational Brain Research and Intervention (C-Brain) Lab, Department of Psychiatry and Behavioral Sciences, School of Medicine, Stanford University, Stanford, California, USA.
- Aging Research Center, Karolinska Institutet and Stockholm University, Stockholm, Sweden.
ORCID-Profile: Jafar Zamani
Förderung
- NIA NIH HHS
- NIMH NIH HHS
- National Institute on Aging
- National Institute of Mental Health
Zitieren
APA
Zamani, J., Vahid, A., Avelar-Pereira, B., Gozdas, E., Hosseini, S. M. H., & Alzheimer's Disease Neuroimaging Initiative (2025). Mapping amyloid beta predictors of entorhinal tau in preclinical Alzheimer's disease. Alzheimer's & Dementia, 21(2). https://doi.org/10.1002/alz.14499
Vancouver
Zamani J, Vahid A, Avelar-Pereira B, Gozdas E, Hosseini SMH, Alzheimer's Disease Neuroimaging Initiative. Mapping amyloid beta predictors of entorhinal tau in preclinical Alzheimer's disease. Alzheimer's & Dementia. 2025;21(2). doi:10.1002/alz.14499
BibTeX
@article{Zamani2025,
author = {Zamani, Jafar and Vahid, Amirali and Avelar-Pereira, Bárbara and Gozdas, Elveda and Hosseini, S M Hadi and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
title = {Mapping amyloid beta predictors of entorhinal tau in preclinical Alzheimer's disease},
journal = {Alzheimer's & Dementia},
year = {2025},
volume = {21},
number = {2},
doi = {10.1002/alz.14499}
}
EUVIMED